Wilmington, Delaware, April 26, 2024 (GLOBE NEWSWIRE) -- The anatomic pathology market is an integral sector within healthcare, facilitating the diagnosis and understanding of diseases through the analysis of tissue samples. It encompasses a diverse array of diagnostic techniques, technologies, and services aimed at elucidating the structural and cellular characteristics of tissues, thereby aiding in treatment decisions and patient management. This market plays a crucial role in various medical specialties, including oncology, infectious diseases, gastroenterology, and dermatology.
One of the primary drivers of growth in the global anatomic pathology market is the increasing incidence and prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders. As these conditions continue to rise globally, there is a growing demand for accurate and timely diagnostic services to guide patient care and treatment strategies. Additionally, advancements in diagnostic technologies and techniques, such as digital pathology, molecular pathology, and immunohistochemistry, are further propelling anatomic pathology market expansion.
Global Anatomic Pathology Market Size and Forecasts Insights
| Market Value in 2023 | US$ 35.6 Bn |
| Market Value Forecast 2034 | US$ 92.8 Bn |
| Growth Rate | 9.1% |
| Historical Data | 2016 – 2022 |
| Base Year | 2023 |
| Forecast Data | 2024 - 2034 |
Digital pathology, in particular, is revolutionizing the field by enabling the digitization of tissue samples and facilitating remote viewing, analysis, and sharing of pathological data. This technology not only enhances workflow efficiency and collaboration among healthcare professionals but also provides opportunities for artificial intelligence (AI) integration and automation, thereby improving diagnostic accuracy and turnaround times. Furthermore, the shift towards personalized medicine is driving innovation and investment in molecular pathology, which involves the analysis of genetic and molecular alterations in tissues to tailor treatment strategies based on individual patient profiles. Molecular diagnostic tests, including polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS), are becoming increasingly integrated into routine pathology practice, enabling precise diagnosis, prognosis prediction, and targeted therapy selection.
In addition to technological advancements, the anatomic pathology market is influenced by factors such as healthcare infrastructure development, reimbursement policies, regulatory frameworks, and industry collaborations. Emerging markets, particularly in Asia-Pacific and Latin America, present significant growth opportunities due to expanding healthcare access, increasing disease burden, and growing investments in healthcare infrastructure.
Speak to our analyst in case of queries before buying this report
Thus, the global anatomic pathology market is poised for continued growth, driven by evolving healthcare needs, technological innovation, and the imperative for accurate and personalized diagnostic solutions to improve patient outcomes.
Global Anatomic Pathology Market: Key Inclusions
- Consumables emerged as the dominant segment in the anatomic pathology market in 2023, capturing the highest share. This was attributed to the consistent demand for consumables such as reagents, stains, slides, and other laboratory supplies essential for sample processing and analysis. With an increasing volume of diagnostic tests performed globally, the demand for consumables remains robust, driven by both routine pathology procedures and the adoption of advanced diagnostic technologies.
- Disease diagnosis segment held a substantial share of the anatomic pathology market in 2023, largely owing to the critical role of pathology in diagnosing various diseases and conditions. As the cornerstone of medical diagnosis, anatomic pathology techniques such as histology, cytology, and molecular pathology are essential for accurately identifying diseases ranging from cancer to infectious diseases. This segment's prominence underscores the fundamental importance of pathology in guiding patient treatment and management strategies.
- Hospitals represent a significant segment in the anatomic pathology market, serving as key hubs for diagnostic services and patient care. With a diverse range of medical specialties and a high volume of patient visits, hospitals drive substantial demand for anatomic pathology services, including tissue biopsy analysis, cancer diagnostics, and disease monitoring. Their role as central healthcare facilities, underscores their importance in driving market growth and innovation within the field of pathology.
- North America maintained its dominance in the global anatomic pathology market in 2023, primarily driven by factors such as robust healthcare infrastructure, high adoption of advanced diagnostic technologies, and increasing incidence of chronic diseases. The region's well-established healthcare systems and significant investments in research and development further bolstered its market leadership.
Request for customization to meet your precise research requirements
Global Anatomic Pathology Market Key Players:
- Agilent Technologies, Inc.
- Avantik
- Cardinal Health
- Danaher
- F. Hoffmann-La Roche AG
- Laboratory Corporation of America Holdings
- NeoGenomics
- PHC Holdings Corporation
- Q2 Solutions
- Quest Diagnostics Incorporated
- Sakura Finetek USA, Inc.
- Other Industry Participants
Global Anatomic Pathology Market
By Type
- Instruments
- Microtomes & Cryostat
- Tissue Processors
- Automatic Stainers
- Whole Slide Imaging (WSI) Scanners
- Others
- Consumables
- Reagents and Stains
- Slides & Coverslips
- Others
- Services
- Autopsy Pathology Services
- Cytogenetics Pathology Services
- Cytopathology Services
- Hematopathology Services
- Molecular Pathology Services
- Neuropathology Services
- Surgical Pathology Services
By Application
- Disease Diagnosis
- Cancer
- Infectious Disease
- Gastrointestinal
- Neuropathology
- Dermatopathology
- Genetic Diseases
- Autoimmune Diseases
- Others
- Drug Discovery and Development
- Others
By End User
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Consult with Our Expert:
Jay Reynolds
The Niche Research
Japan (Toll-Free): +81 663-386-8111
South Korea (Toll-Free): +82-808- 703-126
Saudi Arabia (Toll-Free): +966 800-850-1643
United Kingdom: +44 753-710-5080
United States: +1 302-232-5106
Email: askanexpert@thenicheresearch.com
Website: www.thenicheresearch.com
